June 2012China Biologic received manufacturing approval certificate for Human Coagulation Factor VIII from China Food and Drug Administration (“CFDA”).
October 2011Forbes magazine again named China Biologic to its annual list of Asia’s “200 Best Under a Billion.”
July 2011Shandong Taibang’s newly built plasma collection station in Ningyang county obtained plasma collection license from the Shandong Provincial Health Department and commenced commercial plasma collection.
January 2011China Biologic purchased the remaining 10% equity in Guiyang Dalin Biologic Technologies Co., Ltd.
|FirstPage | PreviousPage | NextPage | LastPage||CurrentPageIndex：4       |